PALVELLA THERAPEUTICS, INC. (PVLA) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2017: $49.75M2018: -$1.07M2019: -$52.47M2020: -$45.90M2021: -$7.66M2022: -$59.93M2023: -$13.70M2024: -$10.84M2025: -$25.01M-$25.01M
2017Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$25.01M-130.7%
2024-$10.84M+20.9%
2023-$13.70M+77.1%
2022-$59.93M-682.4%
2021-$7.66M+83.3%
2020-$45.90M+12.5%
2019-$52.47M-4821.9%
2018-$1.07M-102.1%
2017$49.75M